Abby Turnwald and her team are conducting a study on how parents discuss a neurogenetic diagnosis with their unaffected children. They're seeking families with at least one child with a neurogenetic condition and a sibling aged 7-17 years to participate in a survey.

Until now, scientists interpreted a gene called SYNGAP1 as as only capable of affecting synapses between mature neurons. However, a new study from the Quadrato Lab at USC Stem Cell reveals that certain variations of the gene can disrupt early development in the brain’s cortex.

The SYNGAP1 Foundation, a nonprofit dedicated to improving the lives of families affected by SYNGAP1-related Disorders and a member of The Child Neurology Foundation (CNF), partnered with Unite Us, the nation's leading software company enabling cross-sector collaboration to improve people's health and wellbeing, to fill a gap reported by families in the Child Neurology Foundation's network.

We are deeply honored to have our esteemed Founder, Monica L Dudley, recount her inspiring journey with the Maryland Freemasonry Lodge Corinthian Lodge #93 A.F.&A.M., shedding light on the genesis of a profound legacy and the profound impact of #SYNGAP1.

Buchanan, Ingersoll, and Rooney PC, on behalf of the SYNGAP1 Foundation, will provide pro bono services to develop and execute a government relations strategy aligning SYNGAP1's agenda with the current environment in Washington, D.C.

Buchanan, Ingersoll & Rooney PC to forge a gov relations strategy for SYNGAP1 Foundation, syncing with D.C.'s current climate.

Boosting levels of a variant of the autism-linked protein SYNGAP1 can improve a mouse’s cognition and protect the animal from seizures, according to a new study. The findings, the team says, could inform treatment options for people with mutations in the SYNGAP1 gene, who often have epilepsy, intellectual disability and autism.

SYNGAP1 Foundation is the leading non-profit patient advocacy group dedicated to improving the quality of life for patients and families affected by a SYNGAP1 gene mutation or variant. SYNGAP1 is a gene located in the brain that provides instructions for making a protein, called SynGAP, that plays an important role in nerve cells and early brain development that affects future cognitive ability. Children born with a SYNGAP1 gene mutation or variant are affected by a variety of symptoms, ranging from mild to severe.